Messenger v. Boston Scientific Corporation

CourtDistrict Court, M.D. Louisiana
DecidedJanuary 6, 2020
Docket3:18-cv-00827
StatusUnknown

This text of Messenger v. Boston Scientific Corporation (Messenger v. Boston Scientific Corporation) is published on Counsel Stack Legal Research, covering District Court, M.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Messenger v. Boston Scientific Corporation, (M.D. La. 2020).

Opinion

UNITED STATES DISTRICT COURT

MIDDLE DISTRICT OF LOUISIANA

MELISSA R. MESSENGER CIVIL ACTION VERSUS NO. 18-827-JWD-EWD BOSTON SCIENTIFIC CORPORATION

RULING AND ORDER

This matter comes before the Court on Defendant Boston Scientific Corporation’s (“Defendant” or “Boston Scientific”) Motion to Dismiss Plaintiff’s Second Amended Complaint Pursuant to Rule 12(b)(6) (Doc. 48). Plaintiff Melissa R. Messenger (“Plaintiff” or “Messenger”) opposes the motion. (Doc. 52.) Boston Scientific has filed a reply. (Doc. 53.) Oral argument is not necessary. The Court has carefully considered the law, the facts in the record, and the arguments and submissions of the parties and is prepared to rule. For the following reasons, Defendant’s motion is granted. I. Relevant Factual Background A. Introduction The relevant factual allegations are taken from Plaintiff’s Second Amended Complaint (Doc. 47). They are assumed to be true for purposes of this motion. Thompson v. City of Waco, Tex., 764 F.3d 500, 502–03 (5th Cir. 2014). The factual background is also taken from those exhibits attached to Defendant’s motion that “are referred to in the [P]laintiff's complaint and are central to her claim[s].” Collins v. Morgan Stanley Dean Witter, 224 F.3d 496, 499 (5th Cir. 2000) (citation omitted). On August 27, 2007, Messenger was hired by Boston Scientific to serve as an Interventional Sales Specialist (“ISS”) for its Interventional Cardiology Division in Louisiana. (Sec. Am. Compl. ¶ 3, Doc. 47.) In 2011, Messenger was promoted to the position of Coronary Sales Representative (“CSR”); and, thereafter, in 2014, she was promoted to the position of Therapy Consultant (“TC”). (Id. ¶ 4.) At all relevant times, Messenger was classified by Boston Scientific as a “Field Based Interventional Sales Representative” (“FBISR”). (Id.)

Messenger’s duties as an FBISR for Boston Scientific included attending and observing surgical procedures. (Id. ¶ 5.) Plaintiff alleges: “Because X-Rays and other radiological devices were present and/or used during the surgical procedures being attended and/or observed by FBISRs, said [Boston Scientific] employees, including Messenger, would wear heavy lead vests and/or aprons which. . . were intended to protect against the harmful effects of radiation.” (Id. ¶ 6.) According to Plaintiff, Boston Scientific’s FBISRs, including Messenger, would wear these lead vests and/or aprons for prolonged periods of time, i.e., multiple consecutive hours, while attending and/or observing surgical procedures on behalf of Boston Scientific. (Id. ¶ 7.) Plaintiff alleges that: In the event that an FBISR had a physical impairment, limitation, or disability that rendered wearing the lead vests and/or aprons too physically strenuous or potentially dangerous, [Boston Scientific] had at its disposal at all relevant times hereto the means to accommodate said physical impairment, limitation, or disability so that the FBISR could attend and/or observe surgical procedures and fulfill his or her employment duties.

(Id. ¶ 8.) Specifically, Plaintiff contends that Boston Scientific “had at its disposal at all times relevant hereto lead shields which could be placed in operating rooms and behind which FBISRs could stand or sit while attending and/or observing surgical procedures and performing the essential tasks associated with their positions.” (Id. ¶ 9.) Plaintiff further alleges that Boston Scientific “also had at its disposal at all times relevant hereto surgical control rooms in which FBISRs could stand or sit while attending and/or observing surgical procedures and performing the essential tasks associated with their positions.” (Id. ¶ 10.) According to Plaintiff, standing and/or sitting behind those lead shields and/or in those surgical control rooms obviated the need for Boston Scientific’s FBISRs to wear the cumbersome lead vests and/or aprons while affording employees the same protection against radiation as the vests

and/or aprons. (Id. ¶ 11.) Consequently, Plaintiff alleges “the FBISRs would be able to attend and/or observe surgical procedures and perform their job duties despite physical impairments, limitations, or disabilities that might preclude wearing the lead vest and/or apron.” (Id.) B. Plaintiff’s Health Problems and Leave of Absence While working as an FBISR for Boston Scientific, Messenger purportedly began experiencing significant back pain. (Id. ¶ 12.) Plaintiff alleges that on or about March 20, 2016, she noticed a significant and acute increase in her back pain while working as an FBISR for Boston Scientific. (Id. ¶ 13.) Despite the acute increase in her back pain, Messenger returned to work and fulfilled her duties as an FBISR on or about March 21 and 23, 2016. (Id. ¶ 14.) Thereafter, Messenger sought medical treatment, as her back pain was not subsiding. (Id.)

On March 28, 2016, Messenger’s doctor provided her with a five (5) day excuse from work, i.e., March 28 through April 4, 2016, which Plaintiff alleges that she “understood only limited her from wearing a lead vest and/or apron while performing her work duties as an FBISR.” (Id. ¶ 15.) However, the doctor’s note itself states that “[t]he patient should be excused from: Work for 5 days.” (Def. Ex. 1, Doc. 48-2 at 2 (emphasis added).) 1 From March 28 to April 4, 2016, Messenger continued to work on and off throughout the week. (Sec. Am. Compl. ¶ 16, Doc. 47.) During that time, Boston Scientific neither requested a

1 This doctor’s note is referenced in and incorporated into the operative complaint. (See Sec. Am. Compl. ¶ 15.) It is also central to Plaintiff’s Second Amended Complaint and will thus be considered by the Court. Collins, 224 F.3d at 499. return to work release from Messenger’s treating physician nor advised Messenger that she was not permitted to work in light of the doctor’s note. (Id. ¶ 16.) On April 7, 2016, Messenger received another work excuse from her doctor; this time for two (2) weeks. (Id. ¶ 17.) Again, while Messenger avers in the Second Amended Complaint that

she believed that the doctor’s note “only limited her from wearing a lead vest and/or apron while performing her work duties as an FBISR” (id.), the actual note reads as follows: __X___ May not return to work/school on:_____ 04/07/2016 – 04/21/2016 (Def. Ex. 2, Doc. 48-3 at 3 (emphasis added).)2 Plaintiff alleges that even with the work limitation imposed by her treating doctor as of March 28, 2016 and April 7, 2016, she was “capable of performing and qualified to perform all essential functions and duties of an FBISR for [Boston Scientific] with the reasonable accommodation of a lead shield(s) and/or a surgical control room” which she alleges Boston Scientific had at its disposal. (Sec. Am. Compl. ¶ 18, Doc. 47.) Nevertheless, after being provided with Plaintiff’s April 7, 2016 doctor’s note and despite

being able to accommodate the restrictions contained therein, Boston Scientific purportedly refused to accommodate Messenger and restricted her from returning to any form of activity or work on behalf of Boston Scientific. (Id. ¶ 19.) Messenger alleges that she immediately notified Boston Scientific that she was unaware her doctor’s note would be interpreted to limit her from returning to work in any capacity and explained that the sole purpose of the note was to limit her from wearing a lead vest and/or apron while performing her duties as an FBISR. (Id. ¶ 20-21.) However, despite allegedly being able to accommodate Plaintiff’s physical limitations by providing her with a lead shield and/or surgical control room, Boston Scientific advised Messenger

2 This note is referenced in Plaintiff’s Second Amended Complaint and central to Plaintiff’s claims, so it will be considered by the Court. See Second Amend. Compl. ¶ 17; Collins, 224 F.3d at 499.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Grant v. Lone Star Co.
21 F.3d 649 (Fifth Circuit, 1994)
Foreman v. Babcock & Wilcox Co
117 F.3d 800 (Fifth Circuit, 1997)
Nichols v. Lewis Grocer
138 F.3d 563 (Fifth Circuit, 1998)
Collins v. Morgan Stanley Dean Witter
224 F.3d 496 (Fifth Circuit, 2000)
Felton v. Polles
315 F.3d 470 (Fifth Circuit, 2002)
Briggs v. State of MS
331 F.3d 499 (Fifth Circuit, 2003)
Mayeaux v. Louisiana Health Service & Indemnity Co.
376 F.3d 420 (Fifth Circuit, 2004)
Henson v. Bell Helicopter Textron, Inc.
128 F. App'x 387 (Fifth Circuit, 2005)
Jones v. Robinson Property Group, L.P.
427 F.3d 987 (Fifth Circuit, 2005)
Harrison v. Estes Express Lines
211 F. App'x 261 (Fifth Circuit, 2006)
Jenkins v. Cleco Power, LLC
487 F.3d 309 (Fifth Circuit, 2007)
Crews v. The Dow Chemical Co
287 F. App'x 410 (Fifth Circuit, 2008)
Lormand v. US Unwired, Inc.
565 F.3d 228 (Fifth Circuit, 2009)
National Railroad Passenger Corporation v. Morgan
536 U.S. 101 (Supreme Court, 2002)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Griffin v. United Parcel Service, Inc.
661 F.3d 216 (Fifth Circuit, 2011)
Andrew Amsel v. Texas Water Development Bd
464 F. App'x 395 (Fifth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Messenger v. Boston Scientific Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/messenger-v-boston-scientific-corporation-lamd-2020.